Wells Fargo & Company Forecasts Strong Price Appreciation for MKS (NASDAQ:MKSI) Stock

MKS (NASDAQ:MKSI) had its price objective raised by equities researchers at Wells Fargo & Company from $175.00 to $210.00 in a research note issued to investors on Thursday,Benzinga reports. The firm presently has an “equal weight” rating on the scientific and technical instruments company’s stock. Wells Fargo & Company‘s price target would suggest a potential downside of 4.64% from the company’s current price.

Several other equities research analysts also recently weighed in on MKSI. Wall Street Zen downgraded shares of MKS from a “strong-buy” rating to a “buy” rating in a research report on Saturday, January 3rd. Citigroup raised their target price on shares of MKS from $122.00 to $185.00 and gave the stock a “buy” rating in a research note on Wednesday, November 12th. Cantor Fitzgerald raised their target price on shares of MKS from $200.00 to $300.00 and gave the stock an “overweight” rating in a report on Tuesday. Bank of America upped their price target on shares of MKS from $215.00 to $255.00 and gave the stock a “buy” rating in a report on Thursday. Finally, Needham & Company LLC lifted their price objective on shares of MKS from $210.00 to $260.00 and gave the company a “buy” rating in a report on Thursday. Ten investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $211.33.

MKS Stock Performance

MKS stock traded down $0.52 during mid-day trading on Thursday, reaching $220.21. 301,738 shares of the company’s stock were exchanged, compared to its average volume of 1,073,523. MKS has a one year low of $54.84 and a one year high of $233.11. The business’s fifty day simple moving average is $166.29 and its 200 day simple moving average is $134.80. The firm has a market capitalization of $14.79 billion, a PE ratio of 53.34, a P/E/G ratio of 1.94 and a beta of 1.92. The company has a quick ratio of 1.81, a current ratio of 2.86 and a debt-to-equity ratio of 1.64.

MKS (NASDAQ:MKSI) last posted its quarterly earnings data on Wednesday, November 5th. The scientific and technical instruments company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.80 by $0.13. The business had revenue of $988.00 million for the quarter, compared to the consensus estimate of $963.87 million. MKS had a return on equity of 20.80% and a net margin of 7.25%.MKS’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.72 earnings per share. MKS has set its Q4 2025 guidance at 1.930-2.610 EPS. On average, sell-side analysts expect that MKS will post 6.94 earnings per share for the current year.

Insider Activity

In other news, Director Elizabeth Mora sold 300 shares of MKS stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $158.81, for a total transaction of $47,643.00. Following the completion of the transaction, the director owned 18,963 shares of the company’s stock, valued at $3,011,514.03. The trade was a 1.56% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 0.57% of the company’s stock.

Hedge Funds Weigh In On MKS

Institutional investors and hedge funds have recently made changes to their positions in the business. Greenleaf Trust increased its stake in shares of MKS by 30.5% in the fourth quarter. Greenleaf Trust now owns 2,634 shares of the scientific and technical instruments company’s stock worth $421,000 after buying an additional 615 shares during the last quarter. Aaron Wealth Advisors LLC boosted its stake in MKS by 19.9% in the fourth quarter. Aaron Wealth Advisors LLC now owns 5,372 shares of the scientific and technical instruments company’s stock valued at $858,000 after acquiring an additional 892 shares during the period. eCIO Inc. bought a new position in shares of MKS in the fourth quarter valued at $63,000. Earned Wealth Advisors LLC acquired a new position in MKS in the 4th quarter worth about $204,000. Finally, Blue Trust Inc. boosted its holdings in MKS by 4.5% in the 4th quarter. Blue Trust Inc. now owns 4,227 shares of the scientific and technical instruments company’s stock valued at $675,000 after purchasing an additional 182 shares during the period. 99.79% of the stock is currently owned by hedge funds and other institutional investors.

MKS News Roundup

Here are the key news stories impacting MKS this week:

• Positive Sentiment: Cantor Fitzgerald raised its price target to $300 (overweight), driving substantial upside expectations and helping lift MKSI to new highs. Cantor Fitzgerald Boosts MKS Price Target to $300
• Positive Sentiment: Needham bumped its target to $260 and kept a buy rating, signaling continued analyst confidence in the company’s growth/cycle dynamics. Needham Raises MKSI Price Target to $260
• Positive Sentiment: Bank of America raised its target to $255 and set a buy rating, adding to the cluster of upward revisions that are supporting the stock’s rally. Benzinga Coverage
• Positive Sentiment: TD Cowen also lifted its target to $230 with a buy rating, reinforcing broad analyst upgrading across the sell-side.
• Positive Sentiment: MKSI has recently hit all-time / 52-week highs as the analyst upgrades accumulated, which often attracts momentum buyers. MKS Instruments stock hits all-time high
• Neutral Sentiment: MKS updated Q4 2025 guidance: revenue guidance is roughly in line or slightly above consensus (~$1.0B vs $994.1M consensus) while EPS guidance is effectively flat to marginally below consensus — a mixed signal that moderates upside.
• Neutral Sentiment: The company is meeting lenders about a comprehensive capital-structure refinancing (scheduled lender meetings), which could lower financing costs longer term but adds near-term execution and covenant risk. MKS Plans Comprehensive Capital Structure Refinancing With Lenders
• Negative Sentiment: High valuation and rapid run-up increase the risk of short-term profit-taking or volatility despite positive analyst commentary — investors should weigh upside from raised targets against rich multiples and execution risk.

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.